Generation of Cardiomyocytes in Pipe-Based Microbioreactor Under Segmented Flow.

Area of Science:

• Stem cell biology
• Bioreactor technology
• Cardiomyocyte differentiation

Background:

• Embryonic stem (ES) cells possess broad differentiation potential, initiated by embryoid body (EB) formation.
• Standard ES cell differentiation methods suffer from high EB heterogeneity due to experimental variability, hindering automation and scalability.
• Developing robust methods for controlled ES cell differentiation is crucial for various biomedical applications.

Purpose of the Study:

• To introduce a novel pipe-based microbioreactor (PBM) system for controlled ES cell differentiation.
• To assess the feasibility of the PBM for continuous generation of cardiac cells from ES cells.
• To evaluate the efficiency of cardiomyocyte production using the PBM compared to traditional methods.

Main Methods:

• Development of a pipe-based microbioreactor (PBM) utilizing segmented flow for precise control of environmental parameters.
• Implementation of a continuous process for generating cardiac cells from single ES cell suspension within the PBM.
• Monitoring cardiomyocyte differentiation using genetically modified ES cells expressing EGFP for optical tracking over 10 days.

Main Results:

• Demonstrated the feasibility of the PBM for continuous ES cell culture and EB formation for up to 10 days.
• Achieved efficient cardiac cell production within the PBM, comparable to standard hanging drop protocols.
• Successfully monitored cardiomyocyte development in real-time using EGFP expression within the PBM.

Conclusions:

• The developed PBM technology facilitates robust and scalable production of cardiomyocytes from ES cells.
• This microfluidic bioreactor system shows promise for applications in drug screening and tissue engineering.
• Further development of PBM technology can enhance the reliability of stem cell-derived cell production.